Predicting and Characterizing Neurodegenerative Subtypes with Multimodal Neurocognitive Signatures of Social and Cognitive Processes
Journal of Alzheimer’s Disease 83 (2021) 227–248 227 DOI 10.3233/JAD-210163 IOS Press Predicting and Characterizing Neurodegenerative Subtypes with Multimodal Neurocognitive Signatures of Social and Cognitive Processes Agust´ın Ibanez˜ a,b,c,d,e,1, Sol Fittipaldib,c,f,1, Catalina Trujillog, Tania Jaramillog, Alejandra Torresg, Juan F. Cardonag, Rodrigo Riverah, Andrea Slachevskyi,j, Adolfo Garc´ıab,c,d,k, Maxime Bertouxl and Sandra Baezm,∗ aLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ib´a˜nez, Santiago, Chile bCognitive Neuroscience Center (CNC), Universidad de San Andr´es, Buenos Aires, Argentina cNational Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina dGlobal Brain Health Institute, University of California, San Francisco, CA, USA eGlobal Brain Health Institute, Trinity College Dublin (TCD), Dublin, Ireland f Facultad de Psicolog´ıa, Universidad Nacional de C´ordoba, C´ordoba, Argentina gInstituto de Psicolog´ıa, Universidad del Valle, Cali, Colombia hNeuroradiology Department, Instituto de Neurocirugia, Universidad de Chile, Santiago, Chile iGeroscience Center for Brain Health and Metabolism (GERO), Faculty of Medicine, University of Chile, Santiago, Chile jNeuropsychology and Clinical Neuroscience Laboratory (LANNEC), Physiopathology Department - ICBM, Neuroscience and East Neuroscience Departments, Faculty of Medicine, University of Chile, Santiago, Chile kDepartamento de Ling¨u´ıstica y Literatura, Facultad de Humanidades, Universidad de Santiago de Chile, Santiago, Chile lLille Center of Excellence for Neurodegenerative Disorders (LICEND), CHU Lille, U1172 - Lille Neurosciences & Cognition, Universit´e de Lille, Inserm, Lille, France mUniversidad de los Andes, Bogot´a, Colombia Accepted 11 June 2021 Pre-press 15 July 2021 Abstract. Background: Social cognition is critically compromised across neurodegenerative diseases, including the behavioral variant frontotemporal dementia (bvFTD), Alzheimer’s disease (AD), and Parkinson’s disease (PD).
[Show full text]